Hyperthyroidism and Wegovy: safety, suitability and what to discuss with your prescriber

The misconception worth correcting first: hyperthyroidism does not automatically disqualify you from Wegovy

A common assumption is that any thyroid condition rules out GLP-1 medicines entirely. That is not what the evidence or the Wegovy SmPC says. The thyroid-related contraindication in the semaglutide prescribing information is specific to a personal or family history of medullary thyroid carcinoma (MTC), or to Multiple Endocrine Neoplasia syndrome type 2 (MEN2). These are rare, distinct conditions. Hyperthyroidism (an overactive thyroid producing too much hormone) is a different matter entirely, and its relevance to prescribing is about clinical nuance rather than a hard rule.

That nuance matters, though. An overactive thyroid raises basal metabolic rate, often causes unintentional weight loss, and can drive cardiovascular effects including tachycardia and raised blood pressure. If hyperthyroidism is active and untreated, starting a weight-loss medicine raises legitimate questions: is weight loss actually appropriate right now, and is the cardiovascular system in a stable enough state to tolerate a medicine whose own side-effect profile includes a modest increase in heart rate? Those are questions for your prescriber and, if relevant, your endocrinologist. You can read more about the related question of whether you can take Wegovy with hyperthyroidism on our dedicated page.

The NHS medicines page for semaglutide covers the core cautions and side effects that apply to all patients; that is a good baseline before speaking to a clinician about your specific thyroid history.

What an overactive thyroid actually means for the prescribing conversation

Hyperthyroidism exists on a spectrum. Someone with well-managed Graves' disease whose thyroid function has been stable on carbimazole for two years is in a very different position from someone recently diagnosed whose TSH and T4 are still fluctuating. The prescriber's assessment will likely consider: current thyroid function test results, which treatment you are on and how stable your levels have been, your cardiovascular status, and whether obesity-related comorbidities are present that themselves justify weight management.

Weight in hyperthyroidism can be paradoxical. Some people lose weight significantly during active disease; others, once treated and their metabolism normalises, find they gain it back and then some. If you fall into the second group (overactive thyroid now well controlled, BMI meeting the licensed threshold for Wegovy) the case for treatment may be entirely reasonable. The route to obtaining Wegovy legally in the UK is always a prescription following a thorough clinical review, precisely so that situations like yours are assessed properly rather than filtered out by a blanket rule.

Worth knowing: the interaction profile of semaglutide with antithyroid medicines such as carbimazole or propylthiouracil is not formally documented in the SmPC. This is not the same as saying there is no interaction, it means data are limited, and your prescriber may wish to take advice from whoever manages your thyroid condition before proceeding. Uncertainty in the evidence is itself a clinical fact, and it is covered under the 'what we don't yet know' section below.

Symptoms to watch, and when overlap with hyperthyroidism becomes clinically significant

Both semaglutide and untreated or undertreated hyperthyroidism can produce symptoms that look similar: heart racing, feeling hot, fatigue, nausea, and changes in bowel habit. This overlap is not dangerous in itself, but it does create a monitoring challenge. If you start Wegovy and begin to notice a faster heart rate or palpitations, it may not be obvious whether that reflects a GI side effect, a cardiac effect of the medicine, or a flare of thyroid activity.

The MHRA issued a Drug Safety Update in January 2026 highlighting that GLP-1 medicines including semaglutide are associated with acute pancreatitis as an infrequent but serious risk; severe persistent stomach pain radiating to the back warrants urgent medical review. That warning applies to all patients, and is particularly worth holding in mind if abdominal symptoms emerge and you are trying to distinguish medicine side effects from other causes.

Practically speaking, keeping your GP and your endocrinologist in the loop when starting any new medicine is sensible. The relationship between Wegovy and thyroid conditions more broadly (including the underactive end of the spectrum) is covered in our related pages if you want to read the wider picture. For thyroid cancer history specifically, our page on Wegovy and thyroid cancer addresses the MTC contraindication in detail.

What is still uncertain, and who to talk to before starting

Honest medicine means being direct about the limits of current evidence. Long-term data on semaglutide in people with active or recently controlled hyperthyroidism are limited; the major STEP trials enrolled adults with obesity but did not specifically report outcomes in hyperthyroid subgroups. That gap does not mean the medicine is unsafe in this population, it means individual clinical judgment carries more weight than it does for someone with no thyroid history.

If your thyroid condition is managed by a specialist, loop them in before a weight-management consultation. If it is managed solely by your GP, your GP can write a summary of your current status that a prescriber at a service like ours can review alongside your consultation. Our clinical team's approach is described on the clinical team page, every consultation is read by a named GPhC-registered prescriber, not processed automatically. On a situation as nuanced as hyperthyroidism alongside weight management, that individual clinical read genuinely matters.

Pregnancy, breastfeeding and trying to conceive: Wegovy is not recommended in any of these situations regardless of thyroid status. If hyperthyroidism is being managed during pregnancy, that is a specialist-led conversation that sits outside the scope of any weight-management prescription. For context on why Wegovy is not used in pregnancy, our Wegovy and pregnancy page covers what is known. If you are ready to explore whether treatment might be right for you, the starting point is a free consultation where a prescriber reviews the full picture.